WNK2 and infection: The analysis revealed significant enrichment of m6A in metabolic pathways, such as pyrimidine and purine and drug metabolism, as well as immune related pathways, including mitogen-activated protein kinase (MAPK) signaling, T-cell and B-cell pathways, leukocyte migration, infection, and inflammation.